Cardiovascular diseases
Patient and clinician satisfaction with pharmacological stress agents (PSAs) used in single photon emission computerized tomography myocardial perfusion imaging (SPECT-MPI)
Shields AS, Hudgens S, Spalding JR, Kitt TM, Ojo O, Kristy RM, Mathias A, Morrissey L, Litcher-Kelly L, Houle CR
Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 23rd International Meeting, Baltimore MD, USA 19-23 May 2018.
Psychometric validation of the Heart Failure Caregiver Questionnaire (HF-CQ®)
Strömberg A, Bonner N, Grant L, Bennett B, Chung M, Jaarsma T, Luttik M, Lewis E, Calado F
Patient (2017). https://doi.org/10.1007/s40271-017-0228-x
Development of a content-valid patient-reported measure to assess the statin intolerance experience
Jacobson TA, Edelman SV, Galipeau N, Shields AL, Mallya UG, Koren A, Davidson MH
The Patient – Patient-Centered Outcomes Research
Psychometric analyses of clinical outcome assessment (COA) questionnaires designed to evaluate satisfaction with pharmacological stress agents (PSAS) used in echocardiography
Spalding J, Hudgens S, Litcher-Kelly L, Shields A, Kitt T, Ojo O, Kristy R, Lee E, Mathias A, Morrissey L, Houle C
Poster presented at International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Vienna, Austria, 29th Oct-2nd Nov 2016
Health outcome assessment in chronic thromboembolic pulmonary arterial hypertension patients treated with riociguat: 2-year results from the CHEST-2 long-term extension study
Bonner N, Brockmann B, Busse D, de la Orden M, Gater A, Mathai SC, Minai OA, Teal S
Poster session presented at: the PHA Conference, Dallas, Texas, June 17–19, 2016
Health outcome assessment in pulmonary arterial hypertension patients treated with riociguat: 2-year results from the PATENT-2 long-term extension study
Bonner N, Brockmann B, Busse D, de la Orden M, Gater A, Mathai SC, Minai OA, Teal S
Poster session presented at: the PHA Conference, Dallas, Texas, June 17–19, 2016
Psychometric evaluation of a new patient-reported outcome (PRO) symptom diary for varicose veins: VVSymQ® instrument
Wright DD, Paty J, Turner-Bowker DM, Bradbury A
Patient. Epub ahead of print Mar 25. 2016. DOI 10.1007/s40271-015-0159-3
Development and content validation of a patient-reported outcome measure to evaluate statin intolerance in the real-world
Jacobson TA, Edelman SV, Davidson, M, Galipeau N, Shields AL, Mallya UG, Koren A
Poster presented at the 21st Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Washington DC, USA, 21-25 May 2016
Assessment of patient-reported health status in chronic thromboembolic pulmonary arterial hypertension patients treated with riociguat: 2-year results from the chest-2 extension study
Minai OA, Bonner N, Mathai SC, Busse D, Brockmann B, Teal S, Gater A, de la Orden M
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 18th Annual European Congress, Milan, Italy, 7-11 November 2015
Assessment of patient-reported health status in pulmonary arterial hypertension patients treated with riociguat: 2-year results from the patent-2 extension study
Mathai SC, Bonner N, Minai OA, Busse D, Brockmann B, Teal S, Gater A, de la Orden M
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 18th Annual European Congress, Milan, Italy, 7-11 November 2015
Development and content validity testing of a patient-reported treatment acceptance measure for use in patients receiving treatment via subcutaneous injection
Tatlock S, Grant L, Spertus J, Khan I, Arbuckle R, Manvelian G, Sanchez R
Value Health 2015;18;8:1000-1007
Expert review on development of patient measure for statin intolerance
Foody JM, Sauris A, Edelman SV, Davidson M, Galipaeu N, Shields AL, Jacobson TA
Poster presented at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions. Baltimore, MD USA
Health outcome assessment in chronic thromboembolic pulmonary arterial hypertension patients treated with riociguat: 2-year results from the CHEST-2 long term extension study
Mathai SC, Bonner N, Odufowora-Sita O, Minai OA, Busse D, Brockman B, Teal S, Alston T, Joish V, Gater A
Poster presented at the American Thoracic Society International Conference Denver, CO, USA, May 15-20, 2015
Health outcome assessment in pulmonary arterial hypertension patients treated with riociguat: 2-year results from the PATENT-2 long term extension study
Mathai SC, Bonner N, Odufowora-Sita O, Minai OA, Busse D, Brockman B, Teal S, Alston T, Joish V, Gater A
Poster presented at the American Thoracic Society International Conference Denver, CO, USA, May 15-20, 2015
Psychometric validation of the caregiver burden questionnaire for heart failure (CBQ-HF v4.0)
Strömberg A, Bonner N, Grant L, Bennett B, Chung M, Jaarsma T, Calado F, Deschaseaux C
Eur J Cardiovasc Nurs. 2015; 14: S75-S76
Psychometric validation of the Heart Failure Caregiver Questionnaire (HF-CQv5.0)
Strömberg A, Bonner N, Grant L, Bennett B, Chung ML, Jaarsma T, Luttik ML, Lewis E, Calado F, Deschaseaux C
Poster session presented at the EuroHeartCare Conference, Dubrovnik, Croatia, 14-15 June 2015
Development and content validity testing of a treatment acceptance measure for use in hypercholesterolemia patients receiving treatment via subcutaneous injection
Tatlock S, Grant L, Arbuckle R, Khan I, Manvelian G, Sanchez R
Poster presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 21st Annual International Meeting, Amsterdam, Netherlands, 8-12 November 2014
Development and validation of the AFSymp™: An atrial fibrillation-specific measure of patient-reported symptoms
Arbuckle R, Abetz L, Medin J, Halling K, Kulich K, Edvardsson K, Coyne KS
Patient 2014;7;319-327
Evaluation of the post-stroke checklist (PSC): A pilot study in the United Kingdom and Singapore
Ward AB, Chen C, Norrving B, Gillard P, Walker MF, Blackburn S, Holloway L, Brainin M, Philp I, Global Stroke Community Advisory Panel (GSCAP)
Int J Stroke 2014;9;A100;76-84
Evaluation of the post-stroke checklist (PSC): A follow-up study in Singapore
Chen C, Ward A, Sanin M, Hilal S, Venketasubramanian N, Gillard P, Walker M, Holloway L, Brainin M
Poster session presented at Asia Pacific Stroke Conference, Taipei, Taiwan, 12-14 September 2014
Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies
Morimoto T, Crawford B, Wada K, Ueda S
Poster session presented at: European Society of Cardiology, Amsterdam, Netherlands, 30 August – 4 September 2013
Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
Bonner N, Abetz L, Meunier J, Sikirica M, Mathai SC
Health Qual Life Outcomes. 2013 Oct 3;11:161
Patient- and clinician-reported satisfaction with pharmacological stress agents for single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI)
Hudgens S, Breeze J, Spalding J
J Med Econ 2013;16(6):828-34
Real-world characterization of hypertension patients in Japan: A 1-Year overview
Crawford B, Ong SH, Falvey H
Asian J Pharmaceutical and Clinical Research 2013; 6 (suppl 4): 93-96
Real-world resource utilization and costs following hospitalization of patients with heart failure and preserved ejection fraction in five regions of China
Li X, Crawford B, Wang D, Deschaseaux C, Liu L
Poster presented at: Great Wall International Congress of Cardiology, Beijing, China, October 10 – 13, 2013
A novel conceptual model of caregiver burden in chronic heart failure: a qualitative study
Blackburn S, Humphrey L, Maguire L, Deschaseaux C, Strömberg A
Value Health 2012;15:A378
A novel conceptual model of caregiver burden in chronic heart failure: a qualitative study
Blackburn S, Humphrey L, Maguire L, Deschaseaux C, Strömberg A
Poster presented at the 15th Annual European Congress of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Berlin, Germany, 2012
Development of a patient-reported outcome measure and a clinician-reported outcome measure to assess satisfaction and preference with pharmacological stress agents for single photon emission computed tomography myocardial perfusion imaging
Hudgens S, Kothari S, Spalding J
Qual Life Res 2012;20:30
Development of a post stroke checklist to standardize long-term stroke care
Philp I, Brainin M, Walker M, Ward A, Gillard P, Shields AL, Norrving B and the Global Stroke Community Advisory Board
Journal of Stroke and Cerebrovascular Diseases,12, S1052-3057
Real world patient profile of patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 regions of China
Li XY, Crawford B, Liao YH
Value Health 2012;15:A129
Real world patient profile of patients with Reduced Ejection Fraction Heart Failure (HF-REF) in 5 regions of China
Li XY, Crawford B, Liao YH, Wang D, Sung JC, Zheng J, McDonald J
Poster session presented at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 17th Annual International Meeting, Washington, USA, 2-6 June 2012
Real-world characterization of hypertension patients in Japan: A 1-year overview
Crawford B, Ong SH, Falvey H
Oral presentation at: International Society for Pharmacoeconomics and Outcomes Research (ISPOR), 5th Asia-Pacific Conference, Taipei, Taiwan, 2–4 September 2012
The Caregiver Burden Questionnaire for Chronic Heart Failure (CBQ-CHF): Development and validation
Blackburn S, Strömberg A, Humphrey L, Maguire L, Deschaseaux C
JCard Fail 2012;18:S83
The post-stroke checklist: A tool for standardizing long-term patient follow-up
Ward A, Chen C, Norrving B, Gillard P, Walker M, Blackburn S, Brainin M, Philp I, on behalf of the Global Stroke Community Advisory Board
Presented at the 8th Annual World Stroke Congress, Brasilia, Brazil, October 10-13 2012
Evaluation of the measurement properties of the anti-hypertensive adherence survey
Hudgens S
Value Health 2011;14:A382
Evaluation of the measurement properties of the anti-hypertensive adherence survey
Hudgens S, Lynch J, Pasquale K, Zacker C
Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Madrid, Spain, 2011
How patients with chronic stable angina perceive and live with their disease on an everyday basis?
Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Madrid, Spain, 2011
Relative efficacy of bivalirudin vs. Heparin alone in STEMI patients treated with primary PCI – an indirect treatment comparison
Medic G, Schwenkglenks M, Eijgelshoven I, Smith A, Day J, Plent S, Bergman G, Toward T
Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Madrid, Spain, 2011
Validation of a patient-reported outcome (PRO) measure and a clinician-reported outcome (CRO) measure to assess satisfaction and preference with pharmacological stress agents for Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Hudgens S, Kothari S
Value Health 2011;14:A255
Validation of a patient-reported outcome (PRO) measure and a clinician-reported outcome (CRO) measure to assess satisfaction and preference with pharmacological stress agents for Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)
Hudgens S, Kothari S
Poster presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Madrid, Spain, 2011
Understanding of stroke and coronary heart disease in the UK: an exploratory study
Ayers BN, Myers LB
Psychol Health Med 2010;15:474
Cost-effectiveness of valsartan in Japan: results from the Jikei heart study
Shimizu M, Crawford B, Ikewaki K, Taniguchi I, Kamae I, Dahlof B, Drost P, Mochizuki S
Value Health 2009;12:A151